Meta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neuroleptics

Author: Bech P.   Peuskens J.   Marder S.   Chouinard G.   Hoyberg O.   Huttunen M.   Blin O.   Claus A.  

Publisher: Elsevier

ISSN: 0924-9338

Source: European Psychiatry, Vol.13, Iss.6, 1998-09, pp. : 310-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract